A study to investigate DYSPORT® for the treatment of subjects with loss of bladder control and involuntary urination as a result of spinal cord injury or multiple sclerosis

Update Il y a 5 ans
Reference: EUCTR2015-000507-44

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

• To assess the efficacy of two Dysport® doses (600 units (U) and 800 U), compared to placebo in reducing UI from Baseline to Week 6 following the first investigational medicinal product (IMP) administration.


Inclusion criteria

  • Urinary incontinence caused by neurogenic detrusor overactivity due to either spinal cord injury or multiple sclerosis